Macquarrie has just increased their valuation of acr to $2.98 must be starting to feel the heat from their clients who sold at lower levels .They cite slowing sales and rebates as a major problem not that they are 10+ million short.They are obviously not readng ims figures and eli lilly quarterly update.
Add to My Watchlist
What is My Watchlist?
